NCT00860561View on ClinicalTrials.gov

Faslodex Post Marketing Surveillance

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Breast Cancer
Trial Locations (7)

Unknown

Research Site, Cheonan

Research Site, Daegu

Research Site, Daejeon

Research Site, Iksan

Research Site, Jeonju

Research Site, Seoul

Research Site, Suwon

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY